175 related articles for article (PubMed ID: 9056738)
41. CD44 expression in normal, hyperplastic, and malignant endometrium.
Saegusa M; Hashimura M; Okayasu I
J Pathol; 1998 Mar; 184(3):297-306. PubMed ID: 9614383
[TBL] [Abstract][Full Text] [Related]
42. [Development of the monoclonal antibody to cultured uterine endometrial adenocarcinoma cells (EI)].
Yudate T; Isaka K; Okabe K; Takayama M
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jul; 47(7):635-42. PubMed ID: 7636334
[TBL] [Abstract][Full Text] [Related]
43. Treatment of endometrial hyperplasias with gonadotropin-releasing hormone agonists: pathological, clinical, morphometric, and DNA-cytometric data.
Agorastos T; Bontis J; Vakiani A; Vavilis D; Constantinidis T
Gynecol Oncol; 1997 Apr; 65(1):102-14. PubMed ID: 9103399
[TBL] [Abstract][Full Text] [Related]
44. AgNORs in endometrial lesions.
Kaushik R; Sharma S; Mahajan V; Gulati A; Sharma BB
Indian J Pathol Microbiol; 1999 Oct; 42(4):451-4. PubMed ID: 11127377
[TBL] [Abstract][Full Text] [Related]
45. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
[TBL] [Abstract][Full Text] [Related]
46. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.
Trimble CL; Kauderer J; Zaino R; Silverberg S; Lim PC; Burke JJ; Alberts D; Curtin J
Cancer; 2006 Feb; 106(4):812-9. PubMed ID: 16400639
[TBL] [Abstract][Full Text] [Related]
47. The role of Pipelle Mark II sampling in endometrial disease diagnosis.
Polena V; Mergui JL; Zerat L; Sananes S
Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):233-7. PubMed ID: 17029754
[TBL] [Abstract][Full Text] [Related]
48. Does hysteroscopy improve upon the sensitivity of dilatation and curettage in the diagnosis of endometrial hyperplasia or carcinoma?
Ben-Yehuda OM; Kim YB; Leuchter RS
Gynecol Oncol; 1998 Jan; 68(1):4-7. PubMed ID: 9454651
[TBL] [Abstract][Full Text] [Related]
49. [Production of monoclonal antibody against a newly established human endometrial cancer cell line SNG-II].
Nozawa S; Sakayori M; Takayama Y; Tsukazaki K; Aoki D; Iizuka R; Mukai M; Inaba N
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Apr; 39(4):559-66. PubMed ID: 3295079
[TBL] [Abstract][Full Text] [Related]
50. A primer of endometrial cytology with histological correlation.
Maksem JA; Meiers I; Robboy SJ
Diagn Cytopathol; 2007 Dec; 35(12):817-44. PubMed ID: 18008351
[TBL] [Abstract][Full Text] [Related]
51. [Expression and significance of heat shock protein 70, 90 in endometrial carcinomas].
Bai XX; Chen YQ; Xin XY; Wang WD
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):38-40. PubMed ID: 15132902
[TBL] [Abstract][Full Text] [Related]
52. [Characteristic of cystic glandular hyperplasia as a precursor of endometrial carcinoma].
Yokosuka K; Teshima H; Yamakawa Y; Hasumi K
Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1241-6. PubMed ID: 7844442
[TBL] [Abstract][Full Text] [Related]
53. [Surgical treatment of precancer and cancer of endometrium].
Ivanov S; Khadzhiolov N; Batashki I
Akush Ginekol (Sofiia); 2007; 46(6):12-4. PubMed ID: 17974165
[TBL] [Abstract][Full Text] [Related]
54. Endometrial hyperplasia involving endometrial polyps: report of a series and discussion of the significance in an endometrial biopsy specimen.
Kelly P; Dobbs SP; McCluggage WG
BJOG; 2007 Aug; 114(8):944-50. PubMed ID: 17565613
[TBL] [Abstract][Full Text] [Related]
55. [Study of claudin-4 in the diagnosis and treatment of endometrial carcinoma].
Pan XY; Li X; Che YC; Li X; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):768-71. PubMed ID: 24406135
[TBL] [Abstract][Full Text] [Related]
56. Cellular features of endometrial hyperplasia and well differentiated adenocarcinoma using the Endocyte sampler: Diagnostic criteria based on the cytoarchitecture of tissue fragments.
Norimatsu Y; Shimizu K; Kobayashi TK; Moriya T; Tsukayama C; Miyake Y; Ohno E
Cancer; 2006 Apr; 108(2):77-85. PubMed ID: 16463402
[TBL] [Abstract][Full Text] [Related]
57. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium.
Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM
Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148
[TBL] [Abstract][Full Text] [Related]
58. Production of monoclonal antibody alpha Pro3 recognizing a human prostatic carcinoma antigen.
Ware JL; Paulson DF; Parks SF; Webb KS
Cancer Res; 1982 Apr; 42(4):1215-22. PubMed ID: 6174221
[TBL] [Abstract][Full Text] [Related]
59. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
[TBL] [Abstract][Full Text] [Related]
60. [Abnormal expression of carbohydrate chain and its mechanism in endometrial cancer].
Kubushiro K; Tsukazaki K; Sakuma Y; Nozawa S
Nihon Rinsho; 1995 Jul; 53(7):1753-9. PubMed ID: 7630016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
